Category: Parkinson’s Disease

Study identifies link between COVID-19 and Parkinson’s

Posted on | Posted on jmurphy | Leave a Comment on Study identifies link between COVID-19 and Parkinson’s

2/11/2022 Morgan Liotta News GT Researchers say the virus aggravates brain cells similar to neurodegenerative conditions, flagging potential future risk, but also treatments. Researchers say the virus aggravates brain cells similar to neurodegenerative conditions, flagging potential future risk, but also treatments. Often characterised primarily as a respiratory disease, SARS-CoV-2 is also linked to neurological symptoms as evidence continues to […]

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Posted on | Posted on jmurphy | Leave a Comment on COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality. Parkinson’s disease (PD) is the second most common neurodegenerative disorder and, nowadays the relationship between SARS-CoV-2 outbreak and […]

SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy

Posted on | Posted on jmurphy | Leave a Comment on SARS-CoV-2 and the risk of Parkinson’s disease: facts and fantasy

Marcelo Merello, Kailash P Bhatia, Jose A Obeso Published: November 27, 2020 DOI: https://doi.org/10.1016/S1474-4422(20)30442-7 Lancet Neurology VOLUME 20, ISSUE 2, P94-95, FEBRUARY 2021 During the pandemic it has become clear that severe acure respiratory syndrome coronavirus (SARS-CoV-2) causes not just respiratory disease, but can affect multiple organs and tissues. Of note is the involvement of the CNS […]

Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China

Posted on | Posted on jmurphy | Leave a Comment on Clinical characteristics and outcome of COVID-19 patients with Parkinson’s disease: a hospital-based case–control study in Shanghai, China

Front. Aging Neurosci., 05 May 2023 Sec. Parkinson’s Disease and Aging-related Movement DisordersVolume 15 – 2023 | https://doi.org/10.3389/fnagi.2023.1138418 Li Wu1† Jun Shen1† Yuhan Jiang1 Xiaolei Shen1 Ping Wang1 Xin Nie2 Wenyan Kang3,4* Jianren Liu1* Wei Chen1* Background: Clinical manifestations of Parkinson’s disease (PD) after Corona Virus Disease 2019 (COVID-19) infection are poorly investigated. Objective: We aimed to explore the clinical features and outcomes of hospitalized PD […]

Early-stage trial for Parkinson’s disease therapy shows signs of promise

Posted on | Posted on jmurphy | Leave a Comment on Early-stage trial for Parkinson’s disease therapy shows signs of promise

Small trial of Bemdaneprocel, which aims to replace dopamine-producing neurons, raises hope for treatment. Hannah Devlin Science correspondent 28 Aug 2023 03.00 EDT Scientists have reported early success in a trial of an experimental cell therapy for Parkinson’s disease, raising hope for patients. Bemdaneprocel therapy is at an early stage, and the year-long trial involved just […]

COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Posted on | Posted on jmurphy | Leave a Comment on COVID-19 and neurological disorders: what might connect Parkinson’s disease to SARS-CoV-2 infection

Salvatore Iacono1† Giuseppe Schirò1† Chiara Davì1 Sergio Mastrilli2 Michelle Abbott3 Fabrizio Guajana1 Valentina Arnao4 Paolo Aridon1 Paolo Ragonese1 Cesare Gagliardo1 Claudia Colomba3 Nicola Scichilone5 Marco D’Amelio1* Front. Neurol., 18 May 2023 Sec. Movement Disorders Volume 14 – 2023 | https://doi.org/10.3389/fneur.2023.1172416 SARS-CoV-2 infection leading to Coronavirus disease 19 (COVID-19) rapidly became a worldwide health emergency due to its elevated infecting capacity, morbidity, and mortality. Parkinson’s disease (PD) is the […]

COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

Posted on | Posted on jmurphy | Leave a Comment on COVID-19 and possible links with Parkinson’s disease and parkinsonism: from bench to bedside

npj Parkinson’s Disease volume 6, Article number: 18 (2020) Cite this article Abstract This Viewpoint discusses insights from basic science and clinical perspectives on coronavirus disease 2019 (COVID-19)/severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection in the brain, with a particular focus on Parkinson’s disease. Major points include that neuropathology studies have not answered the central issue of whether the virus enters central […]

Could tiny blood clots cause long COVID’s puzzling symptoms?

Posted on | Posted on jmurphy | Leave a Comment on Could tiny blood clots cause long COVID’s puzzling symptoms?

Scientists debate evidence for a micro-clot hypothesis that has some people pursuing potentially risky treatments Authors: Cassandra Willyard Nature 608, 662-664 (2022)doi: https://doi.org/10.1038/d41586-022-02286-7 When Lara Hawthorne, an illustrator in Bristol, UK, began developing strange symptoms after having COVID-19, she hoped that they weren’t due to the virus. Her initial illness had been mild. “I’ve been triple […]

Study Reveals Possible Causes of Long COVID Brain Fog

Posted on | Posted on jmurphy | Leave a Comment on Study Reveals Possible Causes of Long COVID Brain Fog

Authors: IANS July 2022 A team of international researchers may have uncovered the cause of the neurological conditions seen in patients with long-Covid, such as brain fog. The team from Swinburne University of Technology and La Trobe University in Australia and Luxembourg University in Luxembourg revealed that fragments of proteins from the SARS-CoV-2 virus can […]